XDWL:F:F-db x-trackers MSCI World UCITS DR 1D (EUR)

ETF | Others |

Last Closing

USD 88.912

Change

-0.47 (-0.52)%

Market Cap

USD 1.13B

Volume

7.37K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.09%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.07 (-0.07%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.18 (+0.19%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.07%)

USD 40.74B
0ZC:F Zscaler Inc

-3.10 (-2.00%)

USD 37.92B

ETFs Containing XDWL:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.05% 72% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.05% 69% C- 60% D-
Trailing 12 Months  
Capital Gain 22.44% 73% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.44% 70% C- 60% D-
Trailing 5 Years  
Capital Gain 70.51% 81% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.51% 80% B- 64% D
Average Annual (5 Year Horizon)  
Capital Gain 11.76% N/A N/A 73% C
Dividend Return 11.76% N/A N/A 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.56% N/A N/A 80% B-
Risk Adjusted Return 86.78% N/A N/A 93% A
Market Capitalization 1.13B 74% C 59% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike